PAVmed (PAVM) Operating Expenses (2015 - 2025)

PAVmed has reported Operating Expenses for 11 years, with the latest figure at $6.9 million in Q4 2025.

• For the quarter ending Q4 2025, Operating Expenses rose 31.9% year-over-year to $6.9 million; the trailing twelve-month figure through Dec 2025 stood at $21.9 million (down 37.32% YoY), and the FY2025 full-year result was $21.9 million, down 53.93% from the prior year.
• Operating Expenses for Q4 2025 stood at $6.9 million, up from $4.8 million in the prior quarter.
• The five-year high for Operating Expenses was $24.7 million in Q4 2022, with the low at $4.7 million in Q2 2025.
• Average Operating Expenses over 5 years is $14.4 million, with a median of $15.0 million recorded in 2024.
• Year-over-year, Operating Expenses surged 164.41% in 2021 and tumbled 70.19% in 2024.
• Tracing PAVM's Operating Expenses over 5 years: stood at $20.0 million in 2021, then rose by 23.69% to $24.7 million in 2022, then declined by 29.46% to $17.4 million in 2023, then plunged by 70.19% to $5.2 million in 2024, then surged by 31.9% to $6.9 million in 2025.
• The last three Operating Expenses figures came in at $6.9 million (Q4 2025), $4.8 million (Q3 2025), and $4.7 million (Q2 2025), per Business Quant data.

Peer Comparison